Viewing Study NCT03295227

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:19 AM
Ignite Modification Date: 2025-12-26 @ 4:26 AM
Study NCT ID: NCT03295227
Status: RECRUITING
Last Update Posted: 2025-08-01
First Post: 2017-09-25
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stage III Thymoma AJCC v8 View
None Stage IIIA Thymoma AJCC v8 View
None Stage IIIB Thymoma AJCC v8 View
None Stage IV Thymoma AJCC v8 View
None Stage IVA Thymoma AJCC v8 View
None Stage IVB Thymoma AJCC v8 View
None Unresectable Thymic Carcinoma View
Keywords: